CureVac N.V. (CVAC) Establishes Subsidiary to Advance The RNA Printer(R
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer(R)
March 1, 2022 7:17 AM ESTThe RNA Printer(R) is CureVac's integrated and automated manufacturing solution for RNA vaccines and therapeuticsCureVac RNA Printer GmbH to provide dedicated infrastructure to accelerate development and broaden application range of The RNA Printer(R)Dr. Markus Bergmann appointed as General Manager for CureVac RNA Printer GmbH
TBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / March 1, 2022 / CureVac N.V. (NASDAQ: CVAC), a global biopharmaceutical company... More
